| Execution period | 5 years |
|---|
NSE filing, NSE: KIMS. Summary written from the filing by ALFA Finder's alert engine.
Krishna Institute of Medical Sciences Ltd: key numbers
- Share price
- ₹745.35
- Market cap
- ₹31,305 Cr
- Revenue (annual)
- ₹3,905 Cr
- Net profit (annual)
- ₹241.4 Cr
- P/E (TTM)
- 153.2×Sector 53.8×
- Promoter holding
- 32.66%+0.16% QoQ
- FII holding
- 15.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krishna Institute of Medical Sciences Ltd
All →Krishna Institute of Medical Sciences Other Announcement
KIMS's CARE Ratings monitoring report shows ₹1,311.81 crore of the ₹1,476.45 crore QIP proceeds utilised till Q2 FY27. No deviation from the stated objects was reported.
Krishna Institute of Medical Sciences Investor Presentation: Key Takeaways
Q2 FY27 total revenue Rs13,630 Mn (+41.3% YoY), EBITDA Rs2,789 Mn (20.5% margin), PAT Rs757 Mn (+5.1% YoY). Expansion via 700+ beds planned.
Krishna Institute of Medical Sciences Results Update
KIMS reported Q2 FY27 consolidated revenue of Rs 1,363 Crore, up 41.3% YoY, with PAT of Rs 76 Crore. EBITDA rose 34% YoY to Rs 279 Crore.
Krishna Institute of Medical Sciences Q2 FY27 Results: Net Profit ₹74.6 Cr, Up 3.6% YoY
Krishna Institute of Medical Sciences Ltd reported revenue from operations of ₹1,344 Cr (+39.9% YoY) and net profit of ₹74.6 Cr (+3.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹74.6 Cr · +3.6% YoY
Krishna Institute of Medical Sciences Capacity Expansion
KIMS Saveera Hospital in Anantapur expanded from 250 to 500 beds, with new oncology and mother-and-child blocks inaugurated November 1, 2026. No monetary value disclosed.
- hospital beds
- 250.0 beds
Krishna Institute of Medical Sciences Acquisition Worth ₹15 Cr
KIMS acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for Rs.15 Crore via primary infusion. The Sangli hospital reported FY26 turnover of Rs.80.42 Crore.
- Value
- ₹15.00 Cr
Other management change announcements
All →Lohia Corp Management Change
Lohia Corp's Whole-time Director Rajendra Kumar Arya resigned, effective close of business 04 Nov 2026. He cited retirement from his professional career after about 35 years.
Galaxy Surfactants Management Change
Galaxy Surfactants re-appoints K. Natarajan as Executive Director from 18 February 2027, and its Company Secretary Niranjan Ketkar resigns effective 4 December 2026. Roopali Kamate is appointed CS and Compliance Officer, and SRBC & Co LLP as statutory auditor.
Electrotherm (India) Management Change
Electrotherm's Managing Director Shailesh Bhandari was redesignated Executive Vice Chairman effective November 4, 2026. The change is subject to shareholder approval.
TPL Plastech Management Change
TPL Plastech's CEO Jayesh Ashar resigned effective 30 November 2026, and director Mangesh Sarfare resigned from the board to become CEO from 1 December 2026. The filing is a management reshuffle with no financial amounts.
SIS Management Change
SIS Limited's board approved continuing Mr. Upendra Kumar Sinha as Non-Executive Independent Director after he reached age 75. His term runs until June 28, 2030.
Jyoti Global Plast Management Change
Jyoti Global Plast appointed Akanksha Dhondibhau Bhor as Company Secretary and Compliance Officer, effective November 5, 2026. Mayur Kamtaprasad Dube resigned from the same role, effective November 4, 2026.